Weiyan Liu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Cancer survivorship and care
Papers in
-
- Circular RNAs in diseases 3
- Ubiquitin and proteasome pathways 2
- Wnt/β-catenin signaling in development and cancer 2
- Oncology 5
- Cancer survivorship and care 3
- Co-authors
- Jingfeng Lu (7 shared papers)Jiazhe Liu (7 shared papers)Anwei Mao (6 shared papers)Junbin Ding (5 shared papers)Hongchang Li (6 shared papers)Zhen Yang (5 shared papers)Meifen Zhang (3 shared papers)Meichun Zheng (2 shared papers)
In The Last Decade
Weiyan Liu
37 papers receiving 785 citations
Peers
Comparison fields: 5 of 86
- Cancer Research 192
- Oncology 185
- Drug Discovery 1
- Molecular Biology 318
- Clinical Biochemistry 19
Countries citing papers authored by Weiyan Liu
This map shows the geographic impact of Weiyan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyan Liu more than expected).
Fields of papers citing papers by Weiyan Liu
This network shows the impact of papers produced by Weiyan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyan Liu. The network helps show where Weiyan Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiyan Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 100 | |
| 2 | 2013 | 81 | |
| 3 | 2021 | 68 | |
| 4 | 2016 | 53 | |
| 5 | 2018 | 48 | |
| 6 | 2022 | 38 | |
| 7 | 2021 | 37 | |
| 8 | 2014 | 32 | |
| 9 | 2021 | 28 | |
| 10 | 2020 | 26 | |
| 11 | 2018 | 25 | |
| 12 | 2013 | 25 | |
| 13 | 2016 | 23 | |
| 14 | 2014 | 22 | |
| 15 | 2014 | 20 | |
| 16 | 2016 | 20 | |
| 17 | 2021 | 19 | |
| 18 | 2020 | 19 | |
| 19 | 2013 | 15 | |
| 20 | 2020 | 15 |
About Weiyan Liu
Weiyan Liu is a scholar working on Molecular Biology, Oncology, Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research, having authored 38 papers that have together received 797 indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (4 papers), Cancer survivorship and care (3 papers), Gastric Cancer Management and Outcomes (3 papers), Circular RNAs in diseases (3 papers), Ubiquitin and proteasome pathways (2 papers), interferon and immune responses (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Cancer Research (192 citations), Oncology (185 citations), Drug Discovery (1 citation), Molecular Biology (318 citations) and Clinical Biochemistry (19 citations). Weiyan Liu has collaborated with scholars based in China, Germany and Singapore. Frequent co-authors include Jingfeng Lu, Jiazhe Liu, Anwei Mao, Junbin Ding, Hongchang Li, Zhen Yang, Meifen Zhang, Meichun Zheng, Sally Wai‐Chi Chan and Jindong Li. Their work appears in journals such as Oncotarget, Oncology Reports, Electronics Letters, Cell Cycle and Cell Proliferation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.